J 2021

Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study

CARDOSO, R., F. GUO, T. HEISSER, M. HACKL, P. IHLE et. al.

Základní údaje

Originální název

Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study

Autoři

CARDOSO, R., F. GUO, T. HEISSER, M. HACKL, P. IHLE, H. DE SCHUTTER, N. VAN DAMME, Z. VALERIANOVA, T. ATANASOV, Ondřej MÁJEK (203 Česká republika, domácí), Jan MUŽÍK (203 Česká republika, domácí), M. C. NILBERT, A. J. TYBJERG, K. INNOS, M. MAGI, N. MALILA, A. M. BOUVIER, V. BOUVIER, G. LAUNOY, A. S. WORONOFF, M. CARIOU, M. ROBASZKIEWICZ, P. DELAFOSSE, F. PONCET, A. KATALINIC, P. M. WALSH, C. SENORE, S. ROSSO, I. VINCERZEVSKIENE, V. E. P. P. LEMMENS, M. A. G. ELFERINK, T. B. JOHANNESEN, H. KORNER, F. PFEFFER, M. J. BENTO, J. RODRIGUES, F. A. DA COSTA, A. MIRANDA, V. ZADNIK, T. ZAGAR, A. L. D. MARQUES, R. MARCOS-GRAGERA, M. PUIGDEMONT, J. GALCERAN, M. CARULLA, M. D. CHIRLAQUE, M. BALLESTA, K. SUNDQUIST, J. SUNDQUIST, M. WEBER, A. JORDAN, C. HERRMANN, M. MOUSAVI, A. RYZHOV, M. HOFFMEISTER a H. BRENNER (garant)

Vydání

Lancet Oncology, New York, Elsevier Science INC, 2021, 1470-2045

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30204 Oncology

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 54.433

Kód RIV

RIV/00216224:14110/21:00121970

Organizační jednotka

Lékařská fakulta

UT WoS

000668269600045

Klíčová slova anglicky

colorectal cancer; incidence; mortality; stage distribution; Europe

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 23. 7. 2021 13:32, Mgr. Tereza Miškechová

Anotace

V originále

Findings In countries with long-standing programmes of screening colonoscopy and faecal tests (ie, Austria, the Czech Republic, and Germany), colorectal cancer incidence decreased substantially over time, with AAPCs ranging from -2 center dot 5% (95% CI -2 center dot 8 to -2 center dot 2) to -1 center dot 6% (-2 center dot 0 to -1 center dot 2) in men and from -2 center dot 4% (-2 center dot 7 to -2 center dot 1) to -1 center dot 3% (-1 center dot 7 to -0 center dot 9) in women. In countries where screening programmes were implemented during the study period, age-standardised colorectal cancer incidence either remained stable or increased up to the year screening was implemented. AAPCs for these countries ranged from -0 center dot 2% (95% CI -1 center dot 4 to 1 center dot 0) to 1 center dot 5% (1 center dot 1 to 1 center dot 8) in men and from -0 center dot 5% (-1 center dot 7 to 0 center dot 6) to 1 center dot 2% (0 center dot 8 to 1 center dot 5) in women. Where high screening coverage and uptake were rapidly achieved (ie, Denmark, the Netherlands, and Slovenia), age-standardised incidence rates initially increased but then subsequently decreased. Conversely, colorectal cancer incidence increased in most countries where no large-scale screening programmes were available (eg, Bulgaria, Estonia, Norway, and Ukraine), with AAPCs ranging from 0 center dot 3% (95% CI 0 center dot 1 to 0 center dot 5) to 1 center dot 9% (1 center dot 2 to 2 center dot 6) in men and from 0 center dot 6% (0 center dot 4 to 0 center dot 8) to 1 center dot 1% (0 center dot 8 to 1 center dot 4) in women. The largest decreases in colorectal cancer mortality were seen in countries with long-standing screening programmes.